Paxlovid: A Lifesaver for COVID-19 Patients, but not everyone gets it
Study reveals Low Usage Rates of COVID-19 Antiviral Treatments in Nursing Homes: A Call for Action
Topline:
Recent research published in JAMA reveals a concerning underutilization of Paxlovid, a key antiviral medication for COVID-19, particularly among nursing home residents. Despite its proven effectiveness in reducing hospitalizations and deaths, only a fraction of eligible patients are receiving this potentially lifesaving treatment.



